Compiled from lecture notes, this is a condense but detailed summary of the mitochondrial diseases covered in BHCS3009 module. All the information (and more) is available in one place in a logical order, easy to search and use for revision.
Non-traditional inheritance
• A number of familial diseases which do not conform to patterns expected of Mendelian inheritance
• Do not fit multifactorial inheritance
• 2 main explanations
o Genomic imprinting
o Mitochondrial inheritance
Mitochondria
• Principle sites of ATP production by processes of oxidative phosphorylation
• Most human cells contain several hundred mitochondria
• Mitochondrial DNA (mtDNA) consists of 16,569bp encoding 13 polypeptides, 22 tRNAs and 2
rRNAs
• 2-10 copies of mtDNA in each mitochondrion
• Most of the several hundred polypeptides in mitochondria encoded by nuclear genome
Mitochondrial DNA
• Replication and transcription controlled by
displacement loop – d-loop
Nuclear vs mitochondrial genome
Nuclear genome Mitochondrialgenome
Size (base pairs) 3200 Mb (3.2 x 109 ) 16.6 kb
No. molecules per cell 46 (23/24 different in F/M) thousandscopies of one molecule
Associated protein histones & non-histones largely free of protein
Number of genes ~21,000 protein-coding 37 (13 protein-codingplus 22 tRNAand
22,000+RNA genes ? 2 rRNAgenes)
Gene density 1 gene / 70-140 kb 1 gene / 0.45 kb
Repetitive DNA ~50% very little
Transcription geneby gene continuous
Introns in most genes none
% coding DNA ~2% ~93%
Codon usage different
Recombination at least once per pair of homologues not seen
per meiosis
Inheritance Mendelian (Y paternal) maternal
Mitochondrial function
• Mitochondrial respiratory chain complexes and the oxidative phosphorylation system (OXPHOS)
• Electron/proton pathways along these complexes
• 5 intramitochondrial enzyme complexes
• Complex 1 has 45 subunits, 38 nuclear encoded, 7 mitochondrial encoded
• Variants in any complex can affect function
Mitochondrial disease
• First identified in 1962
• Patient with structurally abnormal mitochondria and a loss of coupling between oxidation and
phosphorylation
• Mutations in genes that regulate mitochondrial functional, both in nuclear DNA and mtDNA
, • 1980s – relevance of mutated mtDNA to human disease
• Matrilinear inheritance applies to those disorders due to variants in mtDNA
• Pedigree of mitochondrial diseases
o Affected males cannot pass disease to his offspring
o Transmission of disease is only through female
o All her offspring, male and female, are affected
o Incomplete penetrance – skips generation where phenotype does not manifest but still
possess variant as next generation shows disease (carriers); affects pedigree analysis
• Largest class of inborn errors of metabolism with collective incidence of 3 in 10,000
• Progressive, debilitating diseases
• May manifest in utero, at birth, childhood or delayed adult onset
• Multisystem disease with very variable clinical progression – any unexplained, progressive,
multisystem illness should be evaluated for mitochondrial disease
• Care includes energy management, physical therapy, nutritional and emotional support
Mitochondrial disease genes
• Subsets of mitochondrial disease genes (338) according to functional roles
• Roles include
o mtDNA maintenance
o expression, translation
o mitochondrial dynamics
o substrate metabolism
o cofactor metabolism
• Modes of inheritance
o Autosomal dominance (AD)
o Autosomal recessive (AR)
o X-linked dominant (XD)
o X-linked recessive (XR)
Nuclear DNA and mitochondrial disease
• Mitochondrial proteins mainly encoded by nuclear genes
• Mutations here can have serious effects on respiratory chain function within mitochondria
• E.g., AR variants in genes encoding proteins in CytC system – SURF1
• E.g., G4.5 (TAZ) is XR – in males, results in Barth syndrome
• E.g., mitochondria myopathy, AD, caused by variants in POLG genes
• Heterogeneity must be present (not all mitochondria affected) else person will die (not viable for
life)
Leigh syndrome
• Clinical diagnosis based mainly on brain imaging, but considerable genetic heterogeneity
• Mutations in nuclear and mtDNA
o Genes in complexes I, II, III, IV or V deficiency
o Genes encoding mt tRNA proteins
o Components of pyruvate dehydrogenase complex
o Some forms of combined OXPHOS deficiency
• More than 90 genes implicated in disorder
Phenotypic heterogeneity
• Wide phenotypic spectrum within and between mt diseases
• Phenotypic variation determined by proportion of mitochondria containing mutation/variant
(depends on level of genetic heterogeneity)
Les avantages d'acheter des résumés chez Stuvia:
Qualité garantie par les avis des clients
Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.
L’achat facile et rapide
Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.
Focus sur l’essentiel
Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.
Foire aux questions
Qu'est-ce que j'obtiens en achetant ce document ?
Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.
Garantie de remboursement : comment ça marche ?
Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.
Auprès de qui est-ce que j'achète ce résumé ?
Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur AH1984. Stuvia facilite les paiements au vendeur.
Est-ce que j'aurai un abonnement?
Non, vous n'achetez ce résumé que pour €12,02. Vous n'êtes lié à rien après votre achat.
